dalbavancin
CHEBI:CHEBI_82721
Definition
A semisynthetic glycopeptide used for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA.
Chemical Information
- Molecular Formula
- C88H100Cl2N10O28
- Molecular Mass
- 1816.69200
- Charge
- 0
- SMILES
- CN[C@@H]1c2ccc(O)c(Oc3cc(O)c(Cl)c(c3)[C@@H]3NC(=O)[C@@H](Cc4ccc(Oc5cc6cc(Oc7ccc(cc7Cl)[C@@H](O)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]6NC3=O)c3ccc(O)c(c3)-c3c(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)cc(O)cc3[C@H](NC7=O)C(=O)NCCCN(C)C)c5O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)C(O)=O)cc4)NC1=O)c2
- InChI
- InChI=1S/C88H100Cl2N10O28/c1-38(2)13-10-8-6-7-9-11-14-61(106)94-70-73(109)75(111)78(86(120)121)128-87(70)127-77-58-31-43-32-59(77)124-55-24-19-42(29-50(55)89)71(107)69-85(119)98-67(80(114)92-25-12-26-100(4)5)48-33-44(102)34-57(125-88-76(112)74(110)72(108)60(37-101)126-88)62(48)47-28-40(17-22-52(47)103)65(82(116)99-69)95-83(117)66(43)96-84(118)68-49-35-46(36-54(105)63(49)90)123-56-30-41(18-23-53(56)104)64(91-3)81(115)93-51(79(113)97-68)27-39-15-20-45(122-58)21-16-39/h15-24,28-36,38,51,60,64-76,78,87-88,91,101-105,107-112H,6-14,25-27,37H2,1-5H3,(H,92,114)(H,93,115)(H,94,106)(H,95,117)(H,96,118)(H,97,113)(H,98,119)(H,99,116)(H,120,121)/t51-,60-,64-,65-,66-,67+,68+,69+,70-,71-,72-,73-,74+,75+,76+,78+,87-,88+/m1/s1
- InChIKey
- KGPGQDLTDHGEGT-SZUNQUCBSA-N
Alternative Names
- BI 397
- BI397
- dalbavancin
- dalbavancin B0
Treatment Applications
-
obsolete cutaneous listeriosisView Disease →
DOID:0050065
-
obsolete Listeria septicaemiaView Disease →
DOID:0050067
-
obsolete Staphylococcus aureus impetigoView Disease →
DOID:0050413
-
Buruli ulcer diseaseView Disease →
DOID:0050456
-
cicatricial pemphigoidView Disease →
DOID:11656
-
impetigoView Disease →
DOID:8504
-
cellulitisView Disease →
DOID:3488
-
erythrasmaView Disease →
DOID:4131
-
Ritter's diseaseView Disease →
DOID:9063
-
gas gangreneView Disease →
DOID:9159
Drug Classification
-
semisynthetic derivativeView Class →
CHEBI:72588
-
monosaccharide derivativeView Class →
CHEBI:63367
-
glycopeptideView Class →
CHEBI:24396
-
carbohydrate acid derivativeView Class →
CHEBI:63436
-
t303857
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 1539239
- oboInOwl#hasDbXref
- Wikipedia:Dalbavancin
- core#notation
- CHEBI:82721
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 1539239
- oboInOwl#hasDbXref
- Wikipedia:Dalbavancin
- oboInOwl#id
- CHEBI:82721
- core#notation
- CHEBI:82721
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_36047
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_113564
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect36361
- owl#annotatedSource
- t304141
- owl#someValuesFrom
- t3046432